Abalone Bio logo
StartupHealth & bio

Abalone Bio

We create activating antibodies to treat diseases others can’t.

Visit abalonebio.comSee on the map
About

Abalone Bio is tackling challenging undrugged targets underlying diseases affecting millions, focusing first cell-specific antibody drugs to treat obesity and metabolic disease without the GI side effects that cause 25% of GLP-1 drug patients to quit after 1 year. + High throughput experimental measurement uniquely leverages AI/ML: We’ve engineered cells to measure antibodies for pharmacological activity, not just structure or binding like others, 100 million at a time, 100X+ the throughput of others. With our large, proprietary activity datasets, we uniquely leverage ML to both unlock the discovery of rare hits and generate optimized hits for challenging targets, starting with G-protein coupled receptors (GPCRs) + Proven success: We have developed antibody agonists (activators) for 2 out of the 8 G-protein coupled receptors ever drugged by biotech. + Pharma traction: We’ve secured 3 partnerships with $3M in revenue and $125M in downstream value. + Externally validated science: We’ve been awarded $7M in non-dilutive grant funding for platform and program development.

Machine LearningSynthetic BiologyTherapeuticsDrug discovery
Facts
Website
abalonebio.com
City
San Francisco
Country
United States
YC batch
Winter 2020
Team
14 people
Stage
Early stage
AI-native
Yes

See it on the San Francisco mapSource Spot something wrong?

More Health & bio in San Francisco

Is this your company?

Claim this profile

Free and instant: prove you run abalonebio.com and edit the profile yourself.

  • Your logo, office address and founder photos
  • The ✓ Verified mark next to Abalone Bio across the site
  • Open roles listed on the Hiring board
  • A followed link back to your website
For your website

A rank card with Abalone Bio's standing on Labspie, or a simple badge. Both link to this profile and update themselves.

Abalone Bio is listed on Labspie